522 related articles for article (PubMed ID: 18376222)
1. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
[TBL] [Abstract][Full Text] [Related]
2. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
4. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
[TBL] [Abstract][Full Text] [Related]
5. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
[TBL] [Abstract][Full Text] [Related]
8. Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report.
Monzen Y; Mori H; Matsumoto S; Takaki H; Yoshida S; Wakisaka M; Ueda S; Mizoguchi H; Ogata J; Kato Y
Radiat Med; 1995; 13(3):149-52. PubMed ID: 7569009
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
11. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H
Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599
[TBL] [Abstract][Full Text] [Related]
13. [Balloon-occluded arterial infusion as chemotherapy in bladder cancer--long-term results].
Mitsuzane K; Kawabata M; Terada M; Nomura S; Sato M; Yamada R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1701-4. PubMed ID: 2117901
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
Chauvet B; Félix-Faure C; Davin JL; Berger C; Vincent P; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():77s-81s. PubMed ID: 9749084
[TBL] [Abstract][Full Text] [Related]
15. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
Int J Oncol; 2010 Oct; 37(4):773-85. PubMed ID: 20811698
[TBL] [Abstract][Full Text] [Related]
16. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
17. Combined modality treatment with bladder preservation for muscle invasive bladder cancer.
Sabaa MA; El-Gamal OM; Abo-Elenen M; Khanam A
Urol Oncol; 2010; 28(1):14-20. PubMed ID: 18818110
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
19. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
20. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
